×
SINTX TECHNOLOGIES, INC EBIT 2012-2024 | SINT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
SINTX TECHNOLOGIES, INC ebit from 2012 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
SINTX TECHNOLOGIES, INC EBIT 2012-2024 | SINT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
SINTX TECHNOLOGIES, INC ebit from 2012 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$196.3B
Intuitive Surgical (ISRG)
$195.1B
Alcon (ALC)
$42.4B
Edwards Lifesciences (EW)
$41.6B
IQVIA Holdings (IQV)
$36.6B
IDEXX Laboratories (IDXX)
$34.2B
DexCom (DXCM)
$28.4B
Waters (WAT)
$22.2B
STERIS (STE)
$21.2B
SONOVA HOLDING (SONVY)
$20.8B
Hologic (HOLX)
$18.3B
Fresenius Medical Care AG KGaA (FMS)
$13B
Sysmex ADR (SSMXY)
$12.9B
Globus Medical (GMED)
$11.5B
Penumbra (PEN)
$9.4B
Masimo (MASI)
$9.3B
Teleflex (TFX)
$8.9B
Glaukos (GKOS)
$7.9B
PROCEPT BioRobotics (PRCT)
$4.9B
Integer Holdings (ITGR)
$4.6B
Veracyte (VCYT)
$3.1B
Inari Medical (NARI)
$2.9B
LivaNova (LIVN)
$2.8B
TransMedics (TMDX)
$2.6B
Nihon Kohden (NHNKY)
$2.5B
Elekta AB (EKTAY)
$2.2B
Tandem Diabetes Care (TNDM)
$2B
Integra LifeSciences Holdings (IART)
$1.8B
RxSight (RXST)
$1.8B
Alphatec Holdings (ATEC)
$1.4B